{"filing":{"accession_number":"0001493152-26-038647","cik":"0001853816","ticker":"DRMAW","company_name":"Dermata Therapeutics, Inc.","form":"8-K","filing_date":"2026-08-17","report_date":"2026-08-16","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1853816/000149315226038647/form8-k.htm"},"events":[{"id":28133,"run_id":25716,"accession_number":"0001493152-26-038647","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"The filing discloses a private placement of 933,064 shares of common stock, 1,360,544 pre-funded warrants, and 4,587,216 series E and F warrants in an unregistered offering under Section 4(a)(2) and Regulation D. The transaction raises approximately $3.4 million in gross proceeds with potential additional proceeds of $6.7 million upon warrant exercise. Company insiders, including the CEO and CFO, participated in the offering, purchasing approximately $2.4 million of securities. This is a classic dilutive equity issuance by a small-cap company raising capital through warrants and pre-funded warrants.","company_name":"Dermata Therapeutics, Inc.","ticker":"DRMAW","filing_date":"2026-08-17","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":29952,"accession_number":"0001493152-26-038647","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The filing discloses a private placement of 933,064 shares of common stock, 1,360,544 pre-funded warrants, and 4,587,216 series E and F warrants in an unregistered offering under Section 4(a)(2) and Regulation D. The transaction raises approximately $3.4 million in gross proceeds with potential additional proceeds of $6.7 million upon warrant exercise. Company insiders, including the CEO and CFO, participated in the offering, purchasing approximately $2.4 million of securities. This is a classic dilutive equity issuance by a small-cap company raising capital through warrants and pre-funded warrants.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-17T12:31:46.822310+00:00","company_name":"Dermata Therapeutics, Inc.","ticker":"DRMAW","filing_date":"2026-08-17"}]}